Fig. 4From: ABO-identical matching has no superiority in long-term survival in comparison to ABO-compatible matching in lung transplantationCumulative retransplantation-free survival for ABO-compatible (N = 49) and ABO-identical (N = 242) LTx for patients with a limited survival up to 1-year (upper left figure), ABO-compatible (N = 49) and ABO-identical LTx (N = 242) up to ten years (upper right figure) and overall survival for ABO-compatible (N = 19) and ABO-identical (N = 112) LTx in emphysema-patients between 1990 and 2016 (bottom left figure). A significant difference in survival was observed between compatible versus identical matching in patients with limited survival up to 1-yearBack to article page